Navigation Links
PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis
Date:5/21/2008

ients with CF."

About Cystic Fibrosis

Cystic fibrosis (CF) is among the most common life-threatening genetic disorders worldwide. According to the Cystic Fibrosis Foundation, CF affects approximately 30,000 adults and children in the United States and, according to the European Cystic Fibrosis Foundation, it affects a similar number of patients in Europe. CF occurs in approximately one of every 3,500 live births, with approximately 1,000 new cases diagnosed each year in the United States. There is a commercially available genetic test to determine if a patient's CF is caused by a nonsense mutation, and it is estimated that nonsense mutations are the cause of CF in approximately 10% of patients in the United States. There is currently no available therapy to correct defective CFTR production and function. Instead, available treatments for CF are designed to alleviate the symptoms of the disease. These treatments include chest physical therapy to clear the thick mucus from the lungs, antibiotics to treat lung infections and a mucus-thinning drug designed to reduce the number of lung infections and improve lung function. In addition, the majority of cystic fibrosis patients take pancreatic enzyme supplements to assist with food absorption in digestion. There is a significant unmet medical need for treatments for the underlying cause of CF. More information regarding CF is available through the Cystic Fibrosis Foundation (http://www.cff.org).

About PTC124

PTC124 is an orally delivered investigational new drug in Phase 2 clinical development for the treatment of genetic disorders due to nonsense mutations. Nonsense mutations are single-point alterations in the genetic code that prematurely stop the translation process, producing a shortened, non- functional protein. PTC124 has restored production of full-length, functional proteins in preclinical genetic disease models harboring nonsense mutations
'/>"/>

SOURCE PTC Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cerenis Therapeutics Completes Phase I Clinical Trial of CER-002 for Treatment of Cardiovascular Disease
2. PacificGMP Completes GMP Product Fill for Trius Therapeutics
3. Velcura Therapeutics, Inc. Reports Successful Phase 1 Clinical Trial of Novel Bone Disease Therapy
4. Vicus Therapeutics Records Last Patient Visit of Phase 2, VT-122 Trial for the Treatment of Cachexia in Patients With Advanced Lung Cancer
5. Cara Therapeutics Initiates Phase 1 Clinical Trial of Novel Analgesic, CR845
6. PTC Therapeutics Announces Initiation of Phase 2b Registration-Directed Clinical Trial of PTC124 in Duchenne/Becker Muscular Dystrophy
7. Halozyme Therapeutics Presents Findings on Combinations of rHuPH20 Enzyme With Bisphosphonates at the American Association for Cancer Research Conference
8. Halozyme Therapeutics Presents Pre-Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association for Cancer Research Conference
9. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
10. Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System
11. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... , September 3, 2015 ... compounds, Organosulfurs, Organic acids, Phenolics, and Others) and by ... beverage, Paints & coatings, and Others) - Global Trends ... segments the Biocides Market with an analysis and forecast ... value. Browse   88 tables and ...
(Date:9/2/2015)... , Sept. 2, 2015 About ... artificial implants used to replace, augment, or repair ... a wide range of applications including cosmetic, spinal, ... are made of different materials such as polymers, ... the global implantable medical devices market to grow ...
(Date:9/2/2015)... LONDON , Sept. 2, 2015 The quantum ... industry, and the key market based on the product includes ... solar cell, chip, sensor, lighting, battery and energy storage, QD ... of different applications for the quantum dot market. The report ... North America , Europe ...
Breaking Medicine Technology:Biocides Market Worth 10.6 Billion USD by 2020 2Biocides Market Worth 10.6 Billion USD by 2020 3Biocides Market Worth 10.6 Billion USD by 2020 4Biocides Market Worth 10.6 Billion USD by 2020 5Global Implantable Medical Devices Market 2015-2019 2Quantum Dot Market by Product , Material, Application, and Geography- Forecast up to 2020 2
... 2011 University Hospitals (UH) Seidman Cancer Center, ... opens to patients on June 6. The ten-story, ... treatments and technology – all in a patient-centered, ... ) The $260 million, 375,000-square-foot hospital ...
... N.J., June 6, 2011 Bayer HealthCare Pharmaceuticals Inc. ... pharadin in SYM ptomatic P rostate ... which is exclusively licensed from Algeta ASA, in patients ... its primary endpoint by significantly improving overall survival.  Based ...
Cached Medicine Technology:University Hospitals Seidman Cancer Center Opens: First Cancer Hospital in Northeast Ohio Offers Nation's Most Advanced Technology and Treatments 2University Hospitals Seidman Cancer Center Opens: First Cancer Hospital in Northeast Ohio Offers Nation's Most Advanced Technology and Treatments 3Bayer's Investigational Compound Radium-223 Chloride Met its Primary Endpoint of Significantly Improving Overall Survival in a Phase III Trial in Patients with Castration-Resistant Prostate Cancer That Has Spread to the Bone 2Bayer's Investigational Compound Radium-223 Chloride Met its Primary Endpoint of Significantly Improving Overall Survival in a Phase III Trial in Patients with Castration-Resistant Prostate Cancer That Has Spread to the Bone 3
(Date:9/3/2015)... ... September 03, 2015 , ... At Renew Man™, we have ... the traditional health care model, where the primary care physician dictates and the patient ... to become educated about their health issues and empowered to choose their own treatment ...
(Date:9/3/2015)... ... September 03, 2015 , ... Local filmmakers and now ... & Michael Habernig from Path 11 Productions have had great success in launching their ... has featured Hay House authors, Teal Swan who is the well known Spiritual Catalyst ...
(Date:9/3/2015)... ... September 03, 2015 , ... Doctor Kayode Sotonwa can be counted on ... His perspective on internal medicine keeps patients happy and healthy, something that is important ... of the season, but even more so in the fall, when holiday eating and ...
(Date:9/2/2015)... ... September 03, 2015 , ... The Aspen Clinic (TAC), ... retreats geared towards kick-starting and inspiring wellness in the Roaring Fork Valley and beyond. ... developing a whole mind-body approach to fitness - we are much more than a ...
(Date:9/2/2015)... ... ... Sara Bleich, Ph.D., associate professor of health and policy ... recognized scholar on obesity prevention and control, has been selected for the prestigious ... graduate of Garrison Forest School, an all-girls’ independent school in Owings Mills, Md., ...
Breaking Medicine News(10 mins):Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 3Health News:Path 11 Podcast Now Features over 20 Metaphysical Discussions on iTunes and Growing 2Health News:Path 11 Podcast Now Features over 20 Metaphysical Discussions on iTunes and Growing 3Health News:Doctor Kayode Sotonwa Highlights Expert Tips for Staying in Shape This Fall 2Health News:TAC Introduces New Retreats for Fall Fitness 2Health News:Dr. Sara Bleich, Garrison Forest Graduate, Selected for 2015-16 Class of White House Fellows 2
... By Steven Reinberg HealthDay Reporter , WEDNESDAY, ... Administration on Wednesday called for new warnings on the labels ... of a slight increased risk of heart disease and diabetes ... announced in May that it was reviewing the prostate cancer ...
... tomography colonography (CTC) otherwise known as virtual colonoscopy ... colorectal cancer (CRC) screening rates, according to a study ... of Roentgenology ( www.ajronline.org ). ... the U.S. "While colonoscopy is currently the preferred test ...
... and engineers from around the world will gather on the ... discuss some of the latest breakthroughs in lasers and optics ... materials, and medicine. Journalists are invited to Frontiers in ... of the Optical Society (OSA), which is being held together ...
... (HealthDay News) -- A hormone receptor normally confined to the ... parts of the body, researchers report. Researchers from the ... with French government scientists, say this common link may offer ... cancer. They evaluated tumor tissue samples from 1,336 men ...
... A common virus that can cause coughing and ... the ability to kill cancer. Harnessing that power, researchers ... Medical Center, are conducting a clinical trial to see if ... By the age of five, most people have been exposed ...
... A new British study reveals why leopards have spots. ... cats to a mathematical model of pattern development in order ... cats, markings. Patterning -- especially irregular or complex patterns ... live in dense habitats, in the trees, and are active ...
Cached Medicine News:Health News:FDA Calls for New Warnings on Some Prostate Cancer Drugs 2Health News:FDA Calls for New Warnings on Some Prostate Cancer Drugs 3Health News:Colorful brains, cooling lasers, disease-detecting lights and more 2Health News:Colorful brains, cooling lasers, disease-detecting lights and more 3Health News:Colorful brains, cooling lasers, disease-detecting lights and more 4Health News:Colorful brains, cooling lasers, disease-detecting lights and more 5Health News:Colorful brains, cooling lasers, disease-detecting lights and more 6Health News:Colorful brains, cooling lasers, disease-detecting lights and more 7Health News:Colorful brains, cooling lasers, disease-detecting lights and more 8Health News:Colorful brains, cooling lasers, disease-detecting lights and more 9Health News:Colorful brains, cooling lasers, disease-detecting lights and more 10Health News:Colorful brains, cooling lasers, disease-detecting lights and more 11Health News:Colorful brains, cooling lasers, disease-detecting lights and more 12Health News:New Tumor Marker May Improve Cancer Detection: Study 2Health News:A redeeming role for a common virus 2
9 mm wide tip. 35 mm from angle to tip....
Double-ended. 5 mm x 7 mm tips. Designated most popular model or size....
Double-ended. 3 mm x 5 mm curette end and 3 mm spatula end....
Double-ended. Semi sharp. Curved 3 mm tips. Angled right and left....
Medicine Products: